EUVIMEDEUVIMED entdecken
Crossref

CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer

Dan Zhang, Runfen Cheng, Jiaxin Gao, Jiyuan Han, Chunsheng Ni, Song Wang, Xiulan Zhao, Baocun Sun, Tieju Liu iD

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2026. Verfasst von Dan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Phosphatidylinositol 3-Kinases, NF-kappa B, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclin L1 (CCNL1) is highly expressed in multiple cancer types and has been linked to poor prognosis. However, the expression pattern of CCNL1 in breast cancer and its specific role in regulating breast cancer progression remain largely unknown. This study used cell and molecular biology techniques to examine how CCNL1 regulates the proliferation, invasion, migration, and epithelial‐mesenchymal transition (EMT) of breast cancer cells. The applied methods encompassed plasmid transfection, Transwell assay, wound‐healing assay, Western blot analysis, co‐immunoprecipitation (Co‐IP), and rescue assay. For the analysis of CCNL1‐related factors and pathways, bioinformatics platforms including Metascape and HURI were also employed. CCNL1 is highly expressed in breast cancer cells and is associated with a poor prognosis. CCNL1 overexpression increased breast cancer cell invasion and migration and accelerated proliferation. Overexpression of CCNL1 was found to upregulate the mesenchymal marker Vimentin and downregulate the epithelial marker E‐cadherin expression. There is close relationship between CCNL1, the NF‐κB and PI3K/AKT signaling pathways. The direct interaction is verified between CCNL1 and DVL3 by Co‐IP, indicating a negative correlation between the two proteins. CCNL1 overexpression affects breast cancer cells' paclitaxel sensitivity through the PI3K/AKT pathway. CCNL1 activates the NF‐κB signaling pathway through its interaction with DVL3; additionally, it promotes the PI3K/AKT pathway. Together, these two mechanisms enable CCNL1 to exert a regulatory role in the progression of breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsPhosphatidylinositol 3-KinasesNF-kappa BProto-Oncogene Proteins c-aktHumansFemaleCell MovementCell ProliferationSignal TransductionEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticCell Line, Tumor

Stichwörter der Autor:innen

CCNL1DVL3NF‐κBPI3K/AKTbreast cancer

Substanzen

Phosphatidylinositol 3-KinasesNF-kappa BProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Pathology, Tianjin Medical University, Tianjin, China.
  • Department of Pathology, General Hospital of Tianjin Medical University, Tianjin, China.
  • Department of Pathology, Cancer Hospital of Tianjin Medical University, Tianjin, China.

ORCID-Profile: Tieju Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, D., Cheng, R., Gao, J., Han, J., Ni, C., Wang, S., Zhao, X., Sun, B., & Liu, T. (2026). CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70090

Vancouver

Zhang D, Cheng R, Gao J, Han J, Ni C, Wang S, et al. CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70090

BibTeX
@article{Zhang2026,
  author = {Zhang, Dan and Cheng, Runfen and Gao, Jiaxin and Han, Jiyuan and Ni, Chunsheng and Wang, Song and Zhao, Xiulan and Sun, Baocun and Liu, Tieju},
  title = {CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70090}
}
Kostenlos starten →